Table 1.

Allelotype Analysis of Resistant and Susceptible C.D2-Chr 4 Congenic Strains

Marker*Pos. (cM)MIAPnd4Pnd4A N15F6Pnd4C N15F7Fv1 N19F11Pnd7 N12F9Pnd7A N15F7Pnd7B N14F8
N10F15N12F14
% PCT + at 300d  0% 6% 38% 18% 14% 21% 20% 42% 
% PCT in BALB/c  43% 37% 42% 42% 37% 57% 43% 42% 
Pctr2 Phenotype  R = D PR = D S = C PR = D PR = D PR = D PR = D S = C 
Predicted Pctr1  
D4Mit84 37.7 
Ifna, D4Mit27 42.6 
D4Mit15 43 
D4Mit153 45.5 
D4Mit28 46 
D4Mit119 49 
D4Mit187 49 
Mtv13, D4Mit31 49.5 
Tal2 (Scl) 49.5 
D4Lgm1 50.6 
D4Rck41 51 
Ccnb1-rs10 50.7 
D4Mit52 54.9 
D4Mit57 56 
D4Mit122 56 
D4Mit37 56.5 
D4Mit148 66 
D4Mit284 69.8 
D4Mit312 69.8 
Gt10 69.8 
D4Mit65 69.8 
D4Mit32 69.8 
D4Mit252 69.8 
D4Mit48 69.8 
D4Mit13 71 
D4Mit126 71 
D4Mit128 71 
D4Mit343 71 
D4Mit341 71 
D4Lgm3 75.3 
Tnfr2 (D4Mit233) 75.5 
D4Mit160 76 
D4Mit340 76 
D4Mit49 76 
D4Mit259 76 
D4Mit285 76 
Xmv8 76.2 
Xmv44 76.4 
Xmv14 76.5 
Xmv9 76.5 
D4Rck128 76.5   
Nppa (Pnd) 76.5 
Fv1 76.5 
D4Nimr1 76.5 
D4Mit310 77 
D4Mit129 77 
D4Mit190 79 
D4Mit33 79 
D4Mit226 79 
D4Mit42 81 
D4Mit180 81 
D4Mit131 81.2 
D4Mit253 81.2 
D4Mit313 81.5 
D4Mit254 81.7 
Pkcz-rs 81.9 
D4Smh6b 82 
Marker*Pos. (cM)MIAPnd4Pnd4A N15F6Pnd4C N15F7Fv1 N19F11Pnd7 N12F9Pnd7A N15F7Pnd7B N14F8
N10F15N12F14
% PCT + at 300d  0% 6% 38% 18% 14% 21% 20% 42% 
% PCT in BALB/c  43% 37% 42% 42% 37% 57% 43% 42% 
Pctr2 Phenotype  R = D PR = D S = C PR = D PR = D PR = D PR = D S = C 
Predicted Pctr1  
D4Mit84 37.7 
Ifna, D4Mit27 42.6 
D4Mit15 43 
D4Mit153 45.5 
D4Mit28 46 
D4Mit119 49 
D4Mit187 49 
Mtv13, D4Mit31 49.5 
Tal2 (Scl) 49.5 
D4Lgm1 50.6 
D4Rck41 51 
Ccnb1-rs10 50.7 
D4Mit52 54.9 
D4Mit57 56 
D4Mit122 56 
D4Mit37 56.5 
D4Mit148 66 
D4Mit284 69.8 
D4Mit312 69.8 
Gt10 69.8 
D4Mit65 69.8 
D4Mit32 69.8 
D4Mit252 69.8 
D4Mit48 69.8 
D4Mit13 71 
D4Mit126 71 
D4Mit128 71 
D4Mit343 71 
D4Mit341 71 
D4Lgm3 75.3 
Tnfr2 (D4Mit233) 75.5 
D4Mit160 76 
D4Mit340 76 
D4Mit49 76 
D4Mit259 76 
D4Mit285 76 
Xmv8 76.2 
Xmv44 76.4 
Xmv14 76.5 
Xmv9 76.5 
D4Rck128 76.5   
Nppa (Pnd) 76.5 
Fv1 76.5 
D4Nimr1 76.5 
D4Mit310 77 
D4Mit129 77 
D4Mit190 79 
D4Mit33 79 
D4Mit226 79 
D4Mit42 81 
D4Mit180 81 
D4Mit131 81.2 
D4Mit253 81.2 
D4Mit313 81.5 
D4Mit254 81.7 
Pkcz-rs 81.9 
D4Smh6b 82 

Shaded areas designate possible locations for the Pctr2 locus.

Abbreviations: Pos, consensus map position in cM from the centromere; N, backcross generations of the congenic; F, filial generations of the congenic; % PCT, percent of PCT-positive mice at day 300; R, resistant; D, DBA/2N; PR, partially resistant; S, susceptible; C, BALB/cAn.

*

Marker refers to the Chr 4 locus examined.

% PCT in BALB/c refers to the incidence of plasmacytomagenesis in 30 or 40 BALB/c controls tested simultaneously with the designated congenic strain.

Close Modal

or Create an Account

Close Modal
Close Modal